{"name":"Pocket Naloxone Corp","slug":"pocket-naloxone-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Naloxone Nasal Spray","genericName":"Naloxone Nasal Spray","slug":"naloxone-nasal-spray","indication":"Opioid overdose reversal (emergency treatment)","status":"phase_3"}]}],"pipeline":[{"name":"Naloxone Nasal Spray","genericName":"Naloxone Nasal Spray","slug":"naloxone-nasal-spray","phase":"phase_3","mechanism":"Naloxone is a competitive opioid receptor antagonist that rapidly blocks opioid effects and reverses opioid overdose.","indications":["Opioid overdose reversal (emergency treatment)","Suspected or known opioid overdose with respiratory depression"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxPLXJ1WmpzU2xJSDZuUDlVaUtwRXJVZDdSWERVTnlfVkVaSUJodVJNcDlENERhZ3UtT1I4UUZWY25qclM2bEcyRXJhdjVLSEplNEpjajhOODVQUWZjUDRVZ2ZCeFlKZ1RENFFHSGotTmVyT3pJSW4xVnRPcXlrS3MwUDBsRUtuYVhoc0tyTXU3NFVHVHJpTWdiTHFwekVkSlplWVdPNzFTQjNNLVRZeVNLTUNjSXdydXdJWXBTTW9KTUJUazZlS2tfbUFXdTRxV1IxUTJ1SDYwQk1QYjlpMEtJUGZZMzBJeGplRWU2c2gtWFBDamNsUmtLNEg2QjlIcG52RlJ2Yg?oc=5","date":"2023-04-13","type":"trial","source":"BioSpace","summary":"NaxSwab™ OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone from an opioid overdose in study - BioSpace","headline":"NaxSwab™ OTC novel naloxone nasal swab successfully administered by children and adults to potentially rescue someone fr","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOdmhwSzJwU2J4cjFkRVMzTWxYbktnQlFsbkR0QTlRU3Nub0N3d3ZUWGhGcTV1NGhEVVdJUHd1cXlKQS0xbTVXUDdJNGM4b0hpTE9oOEZKcFRDZWM5Nzh4YUhXSnFKd0dFZFRaOVVTcnZ2Wi1ldmsyTHBxTlJZeVBIMDE0QUdRTUsxX2c?oc=5","date":"2023-03-29","type":"regulatory","source":"WSJ","summary":"FDA Makes Overdose-Reversal Drug Narcan Available Over-the-Counter - WSJ","headline":"FDA Makes Overdose-Reversal Drug Narcan Available Over-the-Counter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOOFdadjZCck5NWEQ5ME5scVNGYkFLU2VjOEZoblRnSW5zb1Q1N3pfUEZ6MUVIdmtHTDZMUmwzQUI1VHZBVmZiYTFZdDVveFBWQ3R3VkxkckRmZjdBUUoxeWp5UVlQbGVOc3dYb0szeGVCSjc2VS1UeEdZRWJiZkYyVk1QYW0yX196WUlTZVUtZm00cm4wdU5oUVptTnJnLWpqVTRPcFd4Zw?oc=5","date":"2022-12-26","type":"regulatory","source":"Boston Herald","summary":"FDA speeds up review of over-the-counter overdose-reversal drug - Boston Herald","headline":"FDA speeds up review of over-the-counter overdose-reversal drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQcDhYa2JjRW9Vc3R0SUV0MjJwU043YlpMWi1rREVQQTJYWk9hMGlHMnEycU5Ic2dEUWVoaVd4VS1mQXZ2em5rUVY0QXBmR2lybnprWU1HN0pQamIyd2R6VGV6a3B6cUxSUlRQM2lvZThDWjV5UlNJRTN2M2VUQjg1QTlicXhTcnVaNVFjV2NrcE5NNm1CZEE0YU9uLUpHQUpQT0VhTHJwVF8wd2M1ZUhWRGhGTmRFd2FsSlpmSA?oc=5","date":"2016-08-02","type":"pipeline","source":"Modern Healthcare","summary":"Price of drug that reverses opioid overdose on the rise - Modern Healthcare","headline":"Price of drug that reverses opioid overdose on the rise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPUFpPMlJaUGRXVUl5Y2ZRS0VnRDJ5TV9QbGtUakJEbV9GX204MHJIUjcyRGNJaEZpSUphZV9wRlYzUU5XTDF5UERYSXNCRnFtY1IxUjlnR291cDRXYmhITTBuMUh1LUxHREZhUl9wZTZiYXVReXNPNU1xVnN6MU1RUzFyTTJhYXBuN3NHYXFfeDVubzB4aEwwdks0Vml0SVA2bkNrUXFGYS1Zbk5vc2FtMHNhTFF2TGtG?oc=5","date":"2014-05-29","type":"pipeline","source":"Cincinnati Enquirer","summary":"UK professor develops anti-overdose drug - Cincinnati Enquirer","headline":"UK professor develops anti-overdose drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}